Heterogeneity of Helper/inducer T Lymphocytes. II. Effects of Interleukin 4- and Interleukin 2-producing T Cell Clones on Resting B Lymphocytes
Overview
General Medicine
Affiliations
To compare the helper function of murine T cell clones that secrete IL-2 and IFN-gamma (Th1 cells) or IL-4 and IL-5 (Th2), purified resting B cells were stimulated with F(ab')2 rabbit anti-mouse Ig (RAMG) and rabbit Ig-specific, class II MHC-restricted cloned T cells belonging to the two subsets. Both Th2 clones examined induced strong proliferative responses of B cells in the presence of RAMG, as well as the secretion of IgM and IgG1 antibodies. In contrast, the Th1 clones tested failed to stimulate B cell growth or antibody secretion. Th2-mediated B cell activation was dependent on IL-4 and IL-5, and was also inhibited by IFN-gamma or IFN-gamma produced by Th1 cells present in the same cultures. However, the failure of Th1 cells to help resting B cells could not be reversed with neutralizing anti-IFN-gamma antibody. In addition to this inhibitory effect, IFN-gamma was required for the secretion of IgG2a antibody, particularly when B cells were stimulated with polyclonal activators such as LPS. Finally, both sets of T cell clones secreted lymphokines when stimulated with purified B cells and RAMG. These experiments demonstrate that T cells that differ in lymphokine production also differ in their ability to help B cells as a result of cognate interactions at low concentrations of antigens. Moreover, IL-4, IL-5, and IFN-gamma serve different roles in the T cell-dependent proliferative and differentiative responses of resting B lymphocytes.
Obesity-compromised immunity in post-COVID-19 condition: a critical control point of chronicity.
Jang S, Hong W, Moon Y Front Immunol. 2024; 15:1433531.
PMID: 39188722 PMC: 11345197. DOI: 10.3389/fimmu.2024.1433531.
Dittel L, Dittel B, Brod S Immunohorizons. 2022; 6(7):497-506.
PMID: 35868840 PMC: 10394754. DOI: 10.4049/immunohorizons.2200023.
Ingested ACTH blocks Th17 production by inhibiting GALT IL-6.
Dittel L, Dittel B, Brod S J Neurol Sci. 2019; 409:116602.
PMID: 31812846 PMC: 10394755. DOI: 10.1016/j.jns.2019.116602.
A mucosal adjuvant for the inactivated poliovirus vaccine.
Steil B, Jorquera P, Westdijk J, Bakker W, Johnston R, Barro M Vaccine. 2013; 32(5):558-63.
PMID: 24333345 PMC: 3967568. DOI: 10.1016/j.vaccine.2013.11.101.
Myers R, Dunaway C, Nelson M, Trevor J, Morris A, Steele C J Immunol. 2013; 190(12):6287-94.
PMID: 23650614 PMC: 3679253. DOI: 10.4049/jimmunol.1300431.